{"nct_id":"NCT00267748","title":"Sunitinib Malate Schedule 4/2 vs. Sunitinib Malate Continuous Dosing As First-Line Therapy For Metastatic Renal Cell Cancer (RCC)","status":"COMPLETED","status_verified_date":"2011-08","start_date":"2005-12","start_date_type":null,"primary_completion_date":"2010-06","primary_completion_date_type":"ACTUAL","completion_date":"2010-06","completion_date_type":"ACTUAL","phases":["PHASE2"],"tickers":["PFE"]}